Neurona Therapeutics
Clinical trials sponsored by Neurona Therapeutics, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Brain cell injection could tame epilepsy seizures Results expected Jun 2027 (estimated)
-
Brain cell transplant shows promise for Tough-to-Treat epilepsy
Disease control Recruiting nowThis study tests a one-time injection of lab-grown nerve cells (NRTX-1001) into the brain for people with a specific type of epilepsy that doesn't respond to medication. The cells are designed to release a calming chemical called GABA to quiet overactive brain signals. Researcher…
Phase 3 • Sponsor: Neurona Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Brain cell injection could tame epilepsy seizures
Disease control Recruiting nowThis early-stage trial tests a one-time injection of special nerve cells (NRTX-1001) into both sides of the brain in 10 adults with drug-resistant epilepsy. The cells are designed to calm overactive brain signals by releasing GABA. The main goal is safety, but researchers will al…
Phase 1/2 • Sponsor: Neurona Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC